PMID: 6411511Jun 1, 1983Paper

Glibenclamide-associated hypoglycaemia: a report on 57 cases

Diabetologia
K AsplundF Lithner

Abstract

In the largest series of patients with glibenclamide-associated hypoglycaemia reported so far, 51 cases reported to the Swedish Adverse Drug Reactions Advisory Committee and six additional cases are reviewed and related to sales and prescription data of glibenclamide. Median age of the patients with hypoglycaemia was 75 years and 21% were 85 years or above. For comparison, the median age of a random sample (1 in 288 of all patients prescribed glibenclamide) was 70 years and only 5% were 85 years or older. In eight out of 40 cases where duration of glibenclamide treatment was recorded, the hypoglycaemic event occurred during the first month of treatment. The median daily dose of glibenclamide prescribed was 10 mg both in the hypoglycaemic cases and in the prescription sample. Coma or disturbed consciousness was the most common clinical presentation in this series and the minimum blood glucose value was 1.3 mmol/l (median). Twenty-two patients responded immediately to treatment, 24 had protracted hypoglycaemia of 12-72 h duration and 10 died. Fatal outcome was observed even with small doses of glibenclamide (2.5-5 mg/day). Previous strokes and cardiac disorders were isolated as two independent determinants of a serious course of ...Continue Reading

Citations

Jan 1, 1990·European Journal of Clinical Pharmacology·S GeorgeA Cole
Jan 1, 1993·European Journal of Clinical Pharmacology·B H WolffenbuttelA C Kruseman
Jan 1, 1986·European Journal of Clinical Pharmacology·E Wåhlin-BollA Melander
Jan 8, 2011·European Journal of Clinical Pharmacology·Andreas HolsteinJulia Stingl
Feb 22, 2011·European Journal of Clinical Pharmacology·A SurendiranC Adithan
Feb 22, 2012·Zeitschrift für Gerontologie und Geriatrie·A-K Meyer
Sep 30, 2010·International Journal of Legal Medicine·Cornelius HessBurkhard Madea
Feb 22, 2008·Cardiovascular Drugs and Therapy·Partha Kar, Richard I G Holt
Sep 10, 2008·Current Diabetes Reports·Christopher T Kodl, Elizabeth R Seaquist
Feb 27, 2004·European Journal of Pharmacology·Kotaro TakasakiKatsuya Higo
Sep 13, 2003·European Journal of Pharmacology·Takeshi OhtaFumihiko Yonemori
Jun 4, 1999·European Journal of Pharmacology·N FurukawaK Wakitani
Sep 29, 1999·Endocrinology and Metabolism Clinics of North America·V Marks, J D Teale
Jun 1, 1997·Journal of Clinical Epidemiology·T van StaaJ Monette
May 1, 1988·Baillière's Clinical Endocrinology and Metabolism·A Melander
May 1, 1988·Baillière's Clinical Endocrinology and Metabolism
Jul 1, 1997·Baillière's Clinical Endocrinology and Metabolism·A J Scheen
Nov 7, 1998·Diabetes & Metabolism·A J Scheen
May 14, 1999·British Journal of Pharmacology·T OhtaK Wakitani
Feb 27, 1999·Journal of Clinical Pharmacy and Therapeutics·W S YapT M Greenaway
Jun 1, 1990·British Journal of Clinical Pharmacology·S W CoppackA V Rodgers
Sep 1, 1990·British Journal of Clinical Pharmacology·M L Dahl-PuustinenI Wikström
Aug 1, 1990·Journal of Internal Medicine·S Madsbad
Jul 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·S Josephkutty, J M Potter
Oct 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·K AsplundB Lundman
Apr 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·D A HepburnB M Frier
Nov 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·G S Meneilly, D Tessier
Aug 4, 1984·British Medical Journal·I W Campbell
May 10, 1986·British Medical Journal·J S Yudkin
Nov 15, 1986·British Medical Journal·P LudmanG F Joplin
Apr 2, 1988·British Medical Journal·R E Ferner, H A Neil
Oct 1, 1987·Postgraduate Medical Journal·R B Tattersall, A R Scott
Jun 5, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Lauro Figueroa-ValverdeGraciela Ancona-Leon
Jun 8, 2001·Biochemical and Biophysical Research Communications·T NagakuraI Tanaka
Dec 31, 2002·Adverse Drug Reactions and Toxicological Reviews·Maribel Salas, Jaime J Caro
Jul 16, 2003·Clinical Therapeutics·Denise AndersonWalter Nimmo
Aug 10, 2000·Drugs·J M Chehade, A D Mooradian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Related Papers

British Medical Journal
D W Ryan, J Oyston
Diabetic Medicine : a Journal of the British Diabetic Association
K AsplundB Lundman
© 2021 Meta ULC. All rights reserved